Overview

Cell Culture Market Introduction:

The C ell Culture Market is estimated to value over USD 35.6 billion and register a CAGR of over 10.2% from the forecast period 2020 to 2027.
Increasing awareness about the benefits of culture-based vaccines and rising adoption for single-use technologies are the major factors driving the market growth. Growing demand for monoclonal antibodies and rising investments for cell-based research is augmenting the market. Factors such as increasing attention towards personalized medicine and the development of many biopharmaceutical products such as therapeutic and vaccines are driving the market.

Cell Culture Market Overview:
The market is classified into by product, application, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to dominate the growth of the market.
Reagents such as antibiotics are effective towards contamination and possible toxicity and contamination detection kits are more efficient and faster than other direct culture methods. Serum-free media eliminates the risk of contamination posed by viruses. Owing to these factors, there has been a spike in the demand of sera, media and reagents thus propelling the market.
In terms of application, biopharmaceutical production is expected to hold a vast share of the market. The increasing demand for therapeutic proteins is driving the demand for biopharmaceutical production thus positively influencing the market. Rising incidences of diseases have led to more demand for vaccine production which expands the market. The increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines are fueling the market.

In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Strong government support for R&D activities is boosting the presence of the market in the region. In terms of end-users, pharmaceutical and biotechnological companies are the front runners due to their large consumption of cell culture for bioproduction. Expansion of major biopharmaceutical players has also bolstered the market. Asia-Pacific region is predicted to be a lucrative region owing to increasing government support of emerging economies like India and China for biotech research. Large population size and government policies favoring biopharmaceutical manufacturing have lured the prominent players to penetrate into the region.

Prominent players of the market are Lonza, Becton, Dickinson and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific,Thermo Fisher Scientific, Fujifilm.

Competitive Landscape:
● Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centers across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide
● Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market
● Fujifilm in 2018, acquired IS JAPAN CO., LTD, and Irvine Scientific. The move helped Fujifilm enhance regenerative medicine and reagent business, hence bolstering the company's foothold in the market

Cell Culture Market Segmentation :
By Product

Consumables
Sera, Media and Reagents
Vessels
Bioreactor Accessories
Equipment
Supporting Equipment
Bioreactors
Storage Equipment

By Application
● Biopharmaceutical Production
● Diagnostics
● Drug Screening and Development
● Stem Cell Research
● Tissue Engineering & Regenerative Medicine
● Other Applications
By End-User
● Pharmaceutical & Biotechnology Companies
● Hospitals and Diagnostic Laboratories
● Research Institutes
By Region
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World

FutureWise Key Takeaways:
● According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market
● Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market.

Objectives of the Study:
• To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region
• To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com